FDA Approves Pfizer Covid-19 Vaccine For Ages 16+

The FDA announced the authorization of the Pfizer Covid-19 vaccine for use as a booster in people ages 16 and 17. It’s the first Covid-19 vaccine booster authorized for this age group in the United States. About 2.6 million teens will now be eligible for boosters.